The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups

  1. Stenzl, A.
  2. Szmulewitz, R.Z.
  3. Petrylak, D.
  4. Holzbeierlein, J.
  5. Villers, A.
  6. Azad, A.
  7. Alcaraz, A.
  8. Alekseev, B.
  9. Iguchi, T.
  10. Shore, N.D.
  11. Gomez-Veiga, F.
  12. Ivanescu, C.
  13. Rosbrook, B.
  14. Ramaswamy, K.
  15. Ganguli, A.
  16. Haas, G.P.
  17. Armstrong, A.J.
Aldizkaria:
Prostate

ISSN: 1097-0045,  0270-4137

Argitalpen urtea: 2022

Alea: 82

Zenbakia: 13

Orrialdeak: 1237-1247

Mota: Artikulua

DOI: 10.1002/PROS.24396 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus